| The United States Government has approved the sale of a new drug expected to raise the stakes in the male impotence market.
Levitra, the first market rival to the hugely profitable Viagra, is being manufactured by the German firm, Bayer AG, and marketed by the British firm GlaxoSmithKline (GSK) as an alternative oral therapy for erectile dysfunction. Since its cialis soft uk in 1998, sales of Pfizer’s Viagra have risen to nearly $2bn a year. Both pills work in the same manner and doctors warn that both can have serious side effects, especially for men with heart problems.
A third generic cialis tadalafil price comparison
The US Food and Drug Tadalafil dosage
Researchers reported that studies of several thousand men showed that Viagra helped more than 70% improve their As well as the warnings to men with heart conditions, the FDA said Levitra was not for patients with who had suffered a recent heart attack or stroke who have very low blood pressure or uncontrolled high blood pressure.
For otherwise healthy men, Levitra’s main side effects
Lawson Macartney, head of strategic management of GlaxoSmithKline’s cardiovascular, metabolic and urology drugs, said: “We know, from considerable market research, that the GSK expects Levitra to be available in September.
|
-
Home
Pages
-
Categories
Blogroll
-
RSS Feeds
-
Meta
Post a Comment